Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Apple | Mobile |
---|---|
Business Dev & Design Entertainment | Social Media Tech Web Video |
Develops tools and techniques for gastro-intestinal surgical procedures.
Year Established: | 2006 |
Funding: | |
Address: | 3908 Patriot Drive Suite 170 Durham, NC, 27703 USA |
Telephone: | 2147483647 |
Mobile: | |
Fax: | 919-765-8459 |
Mail: | info@transenterix.com |
Company URL: | http://www.transenterix.com |
If you
4/1/10 10:46 AM
Aisling Capital (FKA: Perseus-Soros Management Company),Intersouth Partners,Parish Capital Advisors LLC,Quaker BioVentures, Inc.,SV Life Sciences Advisers,Synergy Life Science Partners
Todd M. Pope
President and Chief Executive Officer
As president and chief executive officer, Todd M. Pope sets the company’s strategic vision and oversees its organic growth. Pope has spent more than 20 years working in key leadership positions within the medical-device industry.
Prior to joining TransEnterix, Pope served as worldwide president of Cordis, a multi-billion-dollar division within Johnson & Johnson’s medical-device sector. He previously held a number of leadership positions within Johnson & Johnson and Boston Scientific.
Pope has a special passion for managing emerging start-ups that have disruptive technologies with the potential to change the landscape of current standard of care.
David Gill
Chief Financial Officer
Charged with the financial management of TransEnterix, David Gill has a wealth of medical device industry and international business experience, including leading three initial public offerings and raising more than $500 million in equity throughout the course of his career.
Previously, Gill served as senior vice president and CFO of NxStage Medical Inc., as senior vice president and CFO at CTI Molecular Imaging Inc., and COO and CFO of Novoste Coroporation, all publicly traded medical-device companies. He holds an MBA with distinction from Emory University and a B.S. with honors from Wake Forest University.
Sal Castro
Vice President, Research and Development
Sal Castro has accumulated more than 60 worldwide patents during his 25 years of experience creating medical devices, most of them in the laparoscopic surgery arena.
Castro began his career with U.S. Surgical Corporation, now known as Covidien. He led the development team at Surgical Dynamics that created the Ray Fusion Cage®, which has become the gold standard in surgically treating degenerative disc disease. Most recently, Castro led the research and development efforts of the capital equipment and disposable medical device group at Gyrus ACMI, an Olympus Medical company.
Tom Miller
Vice President, Operations
Tom Miller manages operations within TransEnterix’s unique rapid-prototype development division. He and his team work with surgeons to turn ideas into realities and then ensure that their designs have both large-scale manufacturability and the ability to enter the market quickly.
Miller came to TransEnterix from the business incubator Synecor, bringing with him more than 25 years of experience in designing and manufacturing medical devices and components. Previously, he served as CEO of M3 Medical and was instrumental in founding rapid prototyping capabilities at Globus Medical.
John R. Tushar
Vice President, Business Development
John R. Tushar manages TransEnterix’s business-development activities, including international partnerships and licensing agreements.
Tushar previously served as director of worldwide market development and strategy for Closure Medical Corp. (part of Ethicon Inc.) and as a global marketing strategist and business development executive for Ethicon Endo-Surgery, both multi-billion-dollar divisions of Johnson & Johnson.
He also served as interim chief executive officer of RemedEase Inc., an early-stage medical-device company that spun out of the University of North Carolina at Chapel Hill Kenan-Flagler Business School’s entrepreneurship program. He holds a master’s degree in strategic management from The Kelley Graduate School of Business at Indiana University.
Tammy Barnes Carrea
Vice President, Quality and Regulatory Affairs
Tammy Barnes Carrea has more than 20 years of experience managing quality and regulatory affairs within the medical-device industry. Her responsibilities include operational- and manufacturing-related compliance, U.S. and international market clearance and post-market regulation.
Previously, Carrea worked with Sicel Technologies, a start-up firm for implantable medical sensors. She also managed regulatory and quality affairs for new product development at Pharmanetics, a coagulation and drug monitoring diagnostics firm.
Carrea holds a bachelor’s of science degree in engineering from North Carolina State University. A member of the Regulatory Affairs Professional Society, she is a certified regulatory affairs professional.
John Witkowski
Vice President, Manufacturing
Responsible for commercial production at TransEnterix, John Witkowski has more than a decade of experience, as well as an expertise in manufacturing-related continuous quality improvement.
In creating and coaching high-performance teams, Witkowski has a proven track record of driving down costs while simultaneously improving quality, delivery and employee safety.
Previously, Witkowski served as director of operations and international customer service at Stryker Orthopaedics. He also served as director of operations at Accelent and as vice president of operations at Monogen, a medical devices diagnostic company. He holds an MBA with honors from Iona College.
Tom Metcalf
Vice President, Sales
Tom Metcalf is responsible for leading TransEnterix’s sales organization, as well as overseeing the rapid market development of the company’s products. He has nearly 20 years of health-care and medical-device sales leadership experience at companies ranging from diverse Fortune 100 conglomerates to entrepreneurial start-ups.
Previously, Metcalf served as national sales director for Johnson & Johnson’s multi-million Cordis Cardiology division. He also held leadership roles at General Electric’s Medical Systems, Boston Scientific and Medical Simulation Corp. As CentriMed’s vice president of sales and marketing, Metcalf led it to a successful merger with Global Healthcare Exchange.
Luke Roush
Vice President, Global Marketing
Luke Roush is responsible for creating the strategy and managing the execution of TransEnterix’s global marketing efforts.
Most recently, Roush served as chief operating officer at Liquidia Technologies, a privately held nanotechnology company focused on biopharmaceutical and alternative energy applications.
Roush previously served as global group marketing manager for Boston Scientific’s neurovascular hemorrhagic stroke business, and held sales and marketing roles of increasing responsibility at Newell Rubbermaid, a Fortune 500 company.
Roush graduated summa cum laude from Duke University, and earned his MBA from Duke University’s Fuqua School of Business